NewGenIvf (NIVF) Income towards Parent Company (2024 - 2025)

NewGenIvf (NIVF) posted quarterly Income towards Parent Company of -$7.7 million for Q4 2025, down 1322.06% YoY from $631498.7 in Q4 2024, and down 146.08% sequentially from $16.7 million in Q3 2025.

NewGenIvf (NIVF) Income towards Parent Company (2024 - 2025) Analysis & Trends

NewGenIvf has disclosed Income towards Parent Company across 2 years of filings, most recently posting -$7.7 million for Q4 2025.

  • In Q4 2025, Income towards Parent Company fell 1322.06% year-over-year to -$7.7 million; the TTM figure through Dec 2025 stood at $8.5 million (up 1581.26% YoY), while the FY2025 annual figure was $9.7 million, up 2152.04% from the prior year.
  • Income towards Parent Company fell to -$7.7 million in Q4 2025, from $16.7 million in the prior quarter.
  • Over the last five years, Income towards Parent Company for NIVF reached as high as $16.7 million in Q3 2025 and fell as low as -$7.7 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn
10 NewGenIvf 25,304.95 -1.41 Mn 524,025.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -7.72 Mn
Dec 31, 2024 -542,684.00